細胞治療技術市場：製品、プロセス、細胞タイプ、エンドユーザー別-2025-2030年の世界予測

細胞治療技術市場は、2023年に194億8,000万米ドルと評価され、2024年には223億1,000万米ドルに達すると予測され、CAGR 14.63％で成長し、2030年には506億9,000万米ドルに達すると予測されています。

細胞治療技術には、病気の治療や予防に生きた細胞を利用する多様な方法論やバイオテクノロジーが含まれます。これらの技術は、腫瘍学、再生医療、血液学など様々な領域で有望視されており、特異的かつ効果的な個別化治療の選択肢を提供しています。細胞治療の必要性は、複雑な医学的課題、特に従来の治療法では解決できなかった課題に対処できる可能性に由来します。開発用途は多岐にわたり、バイオテクノロジー企業、病院、研究機関、学術研究所など、これらの治療法を積極的に開発・展開している最終用途の範囲が大きいです。市場の成長は、幹細胞研究の進展、提携関係の増加、調査研究への多額の投資によって後押しされています。成長の主な要因としては、慢性疾患の増加、資金調達の増加、臨床試験や承認を加速させる有利な規制シナリオなどが挙げられます。新たなビジネスチャンスは、CAR-T細胞の使用拡大、遺伝子編集技術の強化、組織工学のための3Dバイオプリンティングの活用にあります。企業は、革新的なパートナーシップに投資し、新興新興企業を買収し、生産の拡張性に注力することで、これらを活用することができます。しかし、運用コストの高さ、規制の枠組みの厳しさ、遺伝子組み換えや患者の安全をめぐる倫理的懸念など、市場には制約が存在します。これらの課題は、厳密な臨床検証と強固な安全基準の必要性を強調しています。さらに、生産能力に限界があり、特殊なヘルスケア・インフラが必要であることも、広範な普及を妨げる要因となっています。技術革新が必要な分野には、標的を絞った送達システム、細胞の生存性と安定性の向上、自動化とAI駆動プロセスによる製造コストの削減などがあります。患者特異的（自家）細胞療法の現在の限界を回避する同種細胞療法の調査は、アクセシビリティと市場リーチを高める可能性があります。細胞治療市場の性質はダイナミックで、競合が激しく、技術進化が速いため、企業が競争力を維持するためには、機敏性を維持し、継続的に技術革新を行い、規制状況を効果的にナビゲートすることが重要であることが強調されています。

市場力学：急速に進化する細胞治療技術市場の主要市場インサイトを公開

細胞治療技術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患や感染症の世界の増加
  • 細胞治療製造施設のGMP認証の増加
  • 細胞ベースの研究への投資を通じた政府のイニシアチブの急増
• 市場抑制要因
  • 細胞治療技術に関連する高コスト
• 市場機会
  • 個別化医療への継続的な注目
  • ESCに代わる技術としてのiPS細胞の登場
• 市場の課題
  • 熟練した専門家の不足と厳しい規制の枠組み

ポーターのファイブフォース：細胞治療技術市場をナビゲートする戦略ツール

ポーターのファイブフォースは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：細胞治療技術市場における外部からの影響の把握

外部マクロ環境要因は、細胞治療技術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析細胞治療技術市場における競合情勢の把握

細胞治療技術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス細胞治療技術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、細胞治療技術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨細胞治療技術市場における成功への道筋を描く

細胞治療技術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患や感染症の発生が世界中で増加
    • 細胞治療製造施設のGMP認証の増加
    • 細胞ベースの調査への投資による政府の取り組みの急増
  • 抑制要因
    • 細胞治療技術に関連する高コスト
  • 機会
    • 個別化医療への継続的な注力
    • 技術におけるES細胞の代替としてのiPSCの出現
  • 課題
    • 熟練した専門家の不足と厳しい規制枠組み
• 市場セグメンテーション分析
  • 製品：ビッグデータ分析ツールの登場により、細胞治療用ソフトウェアツールの採用が促進される
  • プロセス：細胞保存技術の進歩
  • 細胞の種類：細胞および遺伝子治療におけるヒト細胞の利用の増加
  • エンドユーザー：調査機関への投資を促進する政府の取り組み
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 細胞治療技術市場：製品別

• 消耗品
• 装置
  • 細胞処理装置
  • 使い捨て機器
• ソフトウェア

第7章 細胞治療技術市場：プロセス別

• 細胞の保存、配布、取り扱い
• 細胞処理
• プロセス監視と品質管理

第8章 細胞治療技術市場細胞の種類別

• 動物細胞
• ヒト細胞
  • 分化細胞
  • 幹細胞

第9章 細胞治療技術市場：エンドユーザー別

• ヘルスケアとライフサイエンス
• 調査機関

第10章 南北アメリカの細胞治療技術市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の細胞治療技術市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの細胞治療技術市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Clade Therapeutics、Gadeta B.V.の買収を発表
  • スタートアップ企業セラレス、投資家が細胞治療生産に資金を投入し2億5,500万米ドルを追加
  • NewBiologix、遺伝子・細胞治療の製造に向けた新技術プラットフォームの推進に向け、5,000万米ドルを調達して設立
• 戦略分析と提言

企業一覧

• Anterogen Co., Ltd.
• Atara Biotherapeutics by FUJIFILM Corporation
• Athersys, Inc.
• Becton, Dickinson and Company
• Bluebird Bio, Inc.
• Bristol-Myers Squibb Company
• Cellectis SA
• Danaher Corporation
• ElevateBio
• Gamida Cell
• GE Healthcare
• Gilead Sciences, Inc.
• JCR Pharmaceuticals Co., Ltd.
• Johnson & Johnson Services, Inc.
• Lonza Group Ltd.
• Merck KGaA
• Miltenyi Biotec B.V. & Co. KG
• Novartis AG
• Sartorius AG
• STEMCELL Technologies Inc.
• Takeda Pharmaceutical Company Limited
• Tego Science
• Terumo Bct, Inc.
• Thermo Fisher Scientific, Inc.
• Vericel Corporation

LIST OF FIGURES

• FIGURE 1. CELL THERAPY TECHNOLOGIES MARKET RESEARCH PROCESS
• FIGURE 2. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL THERAPY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
• TABLE 7. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 81. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 82. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 83. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 86. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 87. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 89. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 151. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 189. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 190. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 191. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 192. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 213. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 214. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 215. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 216. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 219. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 220. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 221. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 222. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 242. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 247. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 248. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 254. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 259. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 260. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 266. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 271. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 272. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 278. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

The Cell Therapy Technologies Market was valued at USD 19.48 billion in 2023, expected to reach USD 22.31 billion in 2024, and is projected to grow at a CAGR of 14.63%, to USD 50.69 billion by 2030.

Cell therapy technologies encompass a diverse range of methodologies and biotechnologies that harness living cells to treat or prevent diseases. These technologies hold promise across various domains such as oncology, regenerative medicine, and hematology, offering personalized treatment options that are both specific and effective. The necessity of cell therapy stems from its potential to address complex medical challenges, especially those unmet by traditional treatments. Applications are wide-ranging, with significant end-use scope in biotechnology firms, hospitals, research institutes, and academic labs actively developing and deploying these therapies. Market growth is bolstered by advancements in stem cell research, increasing partnership collaborations, and substantial investment inflows directed toward R&D. Key growth influencers include the rising prevalence of chronic diseases, increased funding, and favorable regulatory scenarios that accelerate clinical trials and approvals. Emerging opportunities lie in expanding the use of CAR-T cells, enhancing gene editing technologies, and leveraging 3D bioprinting for tissue engineering. Firms can capitalize on these by investing in innovative partnerships, acquiring emerging startups, and focusing on scalability of production. However, market limitations exist, such as high operational costs, stringent regulatory frameworks, and ethical concerns surrounding genetic modifications and patient safety. These challenges underscore the necessity for rigorous clinical validation and robust safety standards. Further, limited production capabilities and the need for specialized healthcare infrastructure can impede wide-scale adoption. Areas ripe for innovation include targeted delivery systems, improving cell viability and stability, and reducing manufacturing costs through automation and AI-driven processes. Research into allogenic cell therapy that circumvents current limitations of patient-specific (autologous) cell therapies could enhance accessibility and market reach. The nature of the cell therapy market is dynamic, with high competition and rapid technological evolution, emphasizing the importance for companies to remain agile, continuously innovate, and navigate regulatory landscapes effectively to maintain a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Therapy Technologies Market

The Cell Therapy Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of chronic diseases and infections globally
  • Rising GMP certifications for cell therapy production facilities
  • Surge in government initiatives through investments in cell-based research
• Market Restraints
  • High costs associated with cell therapy technologies
• Market Opportunities
  • Ongoing focus on personalized medicine
  • Emergence of iPSCs as an alternative to ESCs in technologies
• Market Challenges
  • Dearth of skilled professionals and stringent regulatory framework

Porter's Five Forces: A Strategic Tool for Navigating the Cell Therapy Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Therapy Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Therapy Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Therapy Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Therapy Technologies Market

A detailed market share analysis in the Cell Therapy Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Therapy Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Therapy Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Therapy Technologies Market

A strategic analysis of the Cell Therapy Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Technologies Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Atara Biotherapeutics by FUJIFILM Corporation, Athersys, Inc., Becton, Dickinson and Company, Bluebird Bio, Inc., Bristol-Myers Squibb Company, Cellectis SA, Danaher Corporation, ElevateBio, Gamida Cell, GE Healthcare, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Sartorius AG, STEMCELL Technologies Inc., Takeda Pharmaceutical Company Limited, Tego Science, Terumo Bct, Inc., Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Equipment, and Software. The Equipment is further studied across Cell Processing Equipment and Single-Use Equipment.
• Based on Process, market is studied across Cell Preservation, Distribution, & Handling, Cell Processing, and Process Monitoring & Quality Control.
• Based on Cell Type, market is studied across Animal Cells and Human Cells. The Human Cells is further studied across Differentiated Cells and Stem Cells.
• Based on End-User, market is studied across Healthcare & Life Science and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of chronic diseases and infections globally
    • 5.1.1.2. Rising GMP certifications for cell therapy production facilities
    • 5.1.1.3. Surge in government initiatives through investments in cell-based research
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with cell therapy technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing focus on personalized medicine
    • 5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled professionals and stringent regulatory framework
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies
  • 5.2.2. Process: Advancements in cell preservation technologies
  • 5.2.3. Cell type: Rising utilization of human cells in cell and gene therapies
  • 5.2.4. End user: Government initiatives to propel investments in research institutes
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cell Therapy Technologies Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Equipment
  • 6.3.1. Cell Processing Equipment
  • 6.3.2. Single-Use Equipment
• 6.4. Software

7. Cell Therapy Technologies Market, by Process

• 7.1. Introduction
• 7.2. Cell Preservation, Distribution, & Handling
• 7.3. Cell Processing
• 7.4. Process Monitoring & Quality Control

8. Cell Therapy Technologies Market, by Cell Type

• 8.1. Introduction
• 8.2. Animal Cells
• 8.3. Human Cells
  • 8.3.1. Differentiated Cells
  • 8.3.2. Stem Cells

9. Cell Therapy Technologies Market, by End-User

• 9.1. Introduction
• 9.2. Healthcare & Life Science
• 9.3. Research Institutes

10. Americas Cell Therapy Technologies Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cell Therapy Technologies Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Technologies Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Clade Therapeutics Announces the Acquisition of Gadeta B.V.
  • 13.3.2. Startup Cellares adds USD 255 million as investors pour cash into cell therapy production
  • 13.3.3. NewBiologix Launches with USD 50 million to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Anterogen Co., Ltd.
• 2. Atara Biotherapeutics by FUJIFILM Corporation
• 3. Athersys, Inc.
• 4. Becton, Dickinson and Company
• 5. Bluebird Bio, Inc.
• 6. Bristol-Myers Squibb Company
• 7. Cellectis SA
• 8. Danaher Corporation
• 9. ElevateBio
• 10. Gamida Cell
• 11. GE Healthcare
• 12. Gilead Sciences, Inc.
• 13. JCR Pharmaceuticals Co., Ltd.
• 14. Johnson & Johnson Services, Inc.
• 15. Lonza Group Ltd.
• 16. Merck KGaA
• 17. Miltenyi Biotec B.V. & Co. KG
• 18. Novartis AG
• 19. Sartorius AG
• 20. STEMCELL Technologies Inc.
• 21. Takeda Pharmaceutical Company Limited
• 22. Tego Science
• 23. Terumo Bct, Inc.
• 24. Thermo Fisher Scientific, Inc.
• 25. Vericel Corporation